Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2018-09-15 2018-09-15
Drug Identification Number 02125250 02125250
Brand name APO-SUCRALFATE - TAB 1G APO-SUCRALFATE - TAB 1G
Common or Proper name SUCRALFATE SUCRALFATE
Company Name APOTEX INC APOTEX INC
Ingredients SUCRALFATE SUCRALFATE
Strength(s) 1G 1G
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL 500 BTL
ATC code A02BX A02BX
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date
Actual discontinuation date 2018-09-14 2018-09-14
Remaining supply date 2018-09-14 2018-09-14
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments